On November 20, 2023, FibroGen Inc (NASDAQ: FGEN) opened at $0.5525, lower -7.26% from the last session. During the day, the shares moved up to $0.6298 and dropped to $0.524 before settling in for the closing price of $0.57. Price fluctuations for FGEN have ranged from $0.33 to $25.69 over the past 52 weeks.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 9.01%. Company’s average yearly earnings per share was noted 13.95% at the time writing. With a float of $91.58 million, this company’s outstanding shares have now reached $94.17 million.
Considering the fact that the conglomerate employs 592 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is +85.59, operating margin of -213.90, and the pretax margin is -209.52.
FibroGen Inc (FGEN) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of FibroGen Inc is 6.87%, while institutional ownership is 70.51%. The most recent insider transaction that took place on Sep 01, was worth 2,060. In this transaction Director of this company sold 2,000 shares at a rate of $1.03, taking the stock ownership to the 28,866 shares. Before that another transaction happened on Aug 04, when Company’s Director sold 2,000 for $1.91, making the entire transaction worth $3,820. This insider now owns 30,866 shares in total.
FibroGen Inc (FGEN) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 9/29/2023, the company posted -$0.65 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$0.68) by $0.03. This company achieved a net margin of -208.66 while generating a return on equity of -312.90. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.42 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 13.95% per share during the next fiscal year.
FibroGen Inc (NASDAQ: FGEN) Trading Performance Indicators
Check out the current performance indicators for FibroGen Inc (FGEN). In the past quarter, the stock posted a quick ratio of 1.54. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.34.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.06, a number that is poised to hit -0.54 in the next quarter and is forecasted to reach -1.34 in one year’s time.
Technical Analysis of FibroGen Inc (FGEN)
Compared to the last year’s volume of 2.51 million, its volume of 1.97 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 57.75%. Additionally, its Average True Range was 0.09.
During the past 100 days, FibroGen Inc’s (FGEN) raw stochastic average was set at 7.29%, which indicates a significant decrease from 51.98% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 169.39% in the past 14 days, which was higher than the 117.11% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6642, while its 200-day Moving Average is $9.9215. Nevertheless, the first resistance level for the watch stands at $0.5979 in the near term. At $0.6668, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.7037. If the price goes on to break the first support level at $0.4921, it is likely to go to the next support level at $0.4552. Now, if the price goes above the second support level, the third support stands at $0.3863.
FibroGen Inc (NASDAQ: FGEN) Key Stats
There are currently 98,340K shares outstanding in the company with a market cap of 52.03 million. Presently, the company’s annual sales total 140,730 K according to its annual income of -293,650 K. Last quarter, the company’s sales amounted to 40,130 K and its income totaled -63,620 K.